Log inSign up
Log inSign up
Profluent
190 posts
Profluent profile banner
@ProfluentBio

Profluent

@ProfluentBio
Grounded in nature, authored by AI
Emeryville, CA
profluent.bio
Joined September 2022
0 Following
4,163 Followers
RepliesRepliesRepostsRepostsMediaMediaArticlesArticles

Log in or sign up for X

See what’s happening and join the conversation

Continue with phone
or
Log in with username or email
Terms·Privacy·Cookies·Accessibility·US TIDA·Ads Info·© 2026 X Corp.
  • Pinned
    @ProfluentBio
    Profluent
    @ProfluentBio
    Nov 19, 2025
    Today we’re announcing $106M in new funding led by Altimeter Capital and Bezos Expeditions. This brings our total to $150M to scale our frontier AI models which make biology programmable. Our frontier models have generated functional proteins (Nature Biotech, 2023), created the
    00:00
    18
  • @ProfluentBio
    Profluent
    @ProfluentBio
    Sep 30
    We’re partnering with @BioMarin to use our AI models to design novel medicines. Our foundation models unlock proteins with new and improved functions by drawing on the world's largest dataset of unique protein sequences (115B and counting): Profluent’s Protein Atlas BioMarin
    3
  • @ProfluentBio
    Profluent
    @ProfluentBio
    Aug 12
    Stephen Nayfach, our Head of Bioinformatics and Platform R&D, is at @CSHL this week for the Genome Engineering: CRISPR Frontiers event. Find him and say hi if you're there! 👋 He's giving a talk on using our AI models to design CRISPR-Cas9 variants for base editing ("Programming
    1
  • @ProfluentBio
    Profluent
    @ProfluentBio
    Jul 30
    The Profluent team is heading to Summer RosettaCon next week! Find @jeffruffolo, @richardwshuai, @ShiakiMinami, and Alex Hoffnagle and say hi 👋 You can hear Richard talk about E1, our encoder model, on Thur at 1:30pm (“E1: Retrieval-Augmented Protein Encoders for Fitness and
    1
  • @ProfluentBio
    Profluent
    @ProfluentBio
    Jul 9
    A suite of AI-designed base editors, all from one scaffold. The only piece unique to each patient is the guide RNA. That's the shift AI unlocks: rare disease moves from 'one drug at a time' to a platform, built to bring cost down and reach more patients. More on our work with
    2